NVS

Novartis AG Sponsored ADR · NYSE

Sector Health Technology
Industry Pharmaceuticals: Major
Website novartis.com
Employees(FY) 101703
ISIN US66987V1098

Performance

-1.5%

-5.96%

-16.27%

-7.46%

-0.74%

YTD

+3.17%

Profile

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Advanced Technical Analysis

Technical Analysis of NVS 2024-12-20

The stock's Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 56 suggests a neutral stance. Overall, the Technical Score of 33 reinforces the bearish outlook, indicating that the stock may face downward pressure in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NVS

Stock Rank

Recent News & Updates

2024-12-19 08:47
Update: Novartis to Close MorphoSys Sites, Affecting 330 Jobs(MT Newswires)
2024-12-19 07:47
Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs(MT Newswires)
2024-12-19 07:12
Novartis shutters MorphoSys sites, lays off staff(BioPharma Dive)
2024-12-19 05:46
BioAge and Novartis seek drug targets for ageing-related diseases(Pharmaceutical Technology)
2024-12-19 05:20
Novartis says 330 jobs hit as it closes MorphoSys sites(Reuters)
2024-12-18 09:50
BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases(MT Newswires)
2024-12-18 09:43
Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations(Zacks)
2024-12-17 19:45
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic and Anal Cancers(Globenewswire)
2024-12-17 18:45
Novartis AG (NVS): Among the Oversold Global Stocks to Buy Right Now(Yahoo Finance)
2024-12-17 11:40
NVS vs. LLY: Which Stock Should Value Investors Buy Now?(Zacks)
2024-12-17 09:40
Are Investors Undervaluing Novartis (NVS) Right Now?(Zacks)
2024-12-13 02:15
The Zacks Analyst Blog Mastercard, The Procter & Gamble, Novartis AG, IDT and GSI Technology(Zacks)
2024-12-12 15:00
Top Stock Reports for Mastercard, Procter & Gamble & Novartis(Zacks)
2024-12-11 07:45
Monte Rosa Closes Global License Agreement With Novartis(MT Newswires)
2024-12-10 10:54
Novartis Says Longer-Term Data Highlight Kisqali's Efficacy as Early Breast Cancer Treatment(MT Newswires)
2024-12-10 09:00
Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer(GlobeNewswire)
2024-12-09 13:19
Novartis Announces Positive Results From Late-Stage Study on Fabhalta(Zacks)
2024-12-09 05:18
Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta(Clinical Trials Arena)
2024-12-08 12:30
Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML(GlobeNewswire)
2024-12-06 06:45
Novartis Reports 'Positive' Results From Phase 3 Study of Potential Blood Disorder Therapy(MT Newswires)
2024-12-06 01:15
New Phase IIIB data shows Novartis Fabhalta® improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy(GlobeNewswire)
2024-12-04 09:45
Why Novartis (NVS) is a Top Growth Stock for the Long-Term(Zacks)
2024-12-04 07:15
PTC Therapeutics price target raised to $71 from $47 at UBS(TipRanks)
2024-12-03 13:37
Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion(Zacks)
2024-12-03 13:36
PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy(Zacks)
2024-12-03 09:40
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio(Zacks)
2024-12-03 09:17
Novartis and Olema expand alliance with $250m to boost breast cancer trials(Pharmaceutical Technology)
2024-12-03 04:42
Novartis and PTC Therapeutics link to develop Huntington’s therapy(Pharmaceutical Technology)
2024-12-02 22:29
Novartis' $2.9 Billion Huntington's Bet Sends PTC Stock Soaring Over 14%(Yahoo Finance)
2024-12-02 16:56
Novartis wagers billions of dollars on PTC Huntingtons drug(Yahoo Finance)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.